- Dr. Reddy's Laboratories has launched Toripalimab in India, a new immuno-oncology drug for treating nasopharyngeal carcinoma (NPC).
- Toripalimab is the only drug of its kind approved b…
Join the vibrant privacy-ensured Dzambhala community on
Want to give feedback on this story? Write to us at [email protected]